文献速递外周动脉疾病

止血带在大截肢术中的应用效果:系统综述与荟萃分析

Impact of Tourniquet Use in Major Lower Limb Amputation: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-09-17

该系统综述与荟萃分析纳入7项研究共1018条肢体,评估大截肢术中使用止血带的效果。结果显示止血带可减少术中失血、术后血红蛋白下降和手术时间,但总失血量、输血需求及感染、残端修整、死亡率无显著差异,证据质量低或极低,需进一步随机对照试验。

要点

  • 止血带组术中失血较非止血带组减少(平均差-192.09 mL,95%CI -291.67至-92.52,p<.001)。
  • 术后血红蛋白下降止血带组更低(平均差-0.55 g/dL,95%CI -0.80至-0.31,p<.001)。
  • 输血需求、感染、残端修整及死亡率两组无显著差异,证据质量低或极低。

核心结论

  • 使用止血带可能与大截肢术后血红蛋白下降减少和手术时间缩短相关,且对残端感染、修整和死亡率无负面影响,但多数数据为观察性研究,需进一步随机对照试验以产生更高质量证据。

研究设计与样本

  • 系统综述与荟萃分析,检索Embase、MEDLINE和Cochrane数据库自建库至2024年4月,纳入评估大截肢术中使用与不使用止血带的任何研究设计,共纳入7项研究(1项随机对照试验和6项队列研究),总计1018条肢体(止血带组412条,非止血带组606条)。

主要发现

  • 术中失血止血带组较非止血带组减少(平均差-192.09 mL;95%CI -291.67至-92.52;p<.001)。
  • 术后前三至四天总失血量两组无显著差异(平均差-254.66 mL;95%CI -568.12至58.80;p=.11)。
  • 术后血红蛋白下降止血带组较非止血带组更低(平均差-0.55 g/dL;95%CI -0.80至-0.31;p<.001)。
  • 输血需求比值比止血带组对比非止血带组为0.65(95%CI 0.38至1.11;p=.11),每例患者输血单位数两组无显著差异(平均差-0.35,95%CI -0.72至0.03;p=.070)。
  • 手术时间止血带组较非止血带组缩短(平均差-8.69分钟,95%CI -15.95至-1.42;p=.020)。

关键数值与推荐

  • 手术部位感染率两组无显著差异(OR 1.07,95%CI 0.60至1.90;p=.82)。
  • 残端修整率两组无显著差异(OR 0.71,95%CI 0.43至1.16;p=.17)。
  • 死亡率两组无显著差异(OR 0.80,95%CI 0.49至1.30;p=.36)。
  • 所有结局的GRADE证据质量均为低或极低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数数据为观察性研究。
  • 所有结局的GRADE证据质量均为低或极低。
  • 需进一步随机对照试验以产生更高质量证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intra-operative blood loss is a significant complication of major lower limb amputation (MLLA). This systematic review and meta-analysis assessed the effect of tourniquet use on patients undergoing amputation. DATA SOURCES: Embase, MEDLINE, and Cochrane databases were searched from inception to April 2024. REVIEW METHODS: Inclusion criteria were any study design assessing MLLA with and without tourniquet use. Primary outcomes were peri-operative blood loss and transfusion requirements. Secondary outcomes were operative duration, surgical site infection, stump revision, and mortality. Articles were screened and data extracted independently by two reviewers, then pooled using random effects meta-analysis, and presented with their GRADE certainty. Risk of bias was assessed using ROBINS-I and Cochrane RoB 2 tools. RESULTS: Seven studies (one randomised controlled trial [RCT] and six cohort studies) were included, totalling 1 018 limbs (412 tourniquet, 606 non-tourniquet). Intra-operative blood loss was lower with tourniquet use (mean difference [MD] -192.09 mL; 95% confidence interval [CI] -291.67 - -92.52; p < .001); however, there was no significant difference in total blood loss measured over the first three to four post-operative days (MD -254.66 mL; 95% CI -568.12 - 58.80; p = .11). Post-operative haemoglobin drop was lower for tourniquet patients (MD -0.55 g/dL; 95% CI -0.80 - -0.31; p < .001). The odds ratio (OR) for requiring blood transfusion was 0.65 (95% CI 0.38 - 1.11; p = .11) for tourniquet vs. non-tourniquet patients, with no significant difference in the number of units transfused per patient (MD -0.35, 95% CI -0.72 - 0.03; p = .070). Operation duration was shorter with tourniquet use (MD -8.69 minutes, 95% CI -15.95 - -1.42; p = .020). There was no significant difference in rates of surgical site infection (OR 1.07, 95% CI 0.60 - 1.90; p = .82), stump revision (OR 0.71, 95% CI 0.43 - 1.16; p = .17), or death (OR 0.80, 95% CI 0.49 - 1.30; p = .36). GRADE certainty was low or very low for all outcomes. CONCLUSION: Tourniquet use may be associated with reduced post-operative haemoglobin drop and operative duration, without negative consequences on stump infection, revision, and mortality. However, most data are observational. Further RCTs are needed to generate higher quality evidence.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Shea J, Smith E, Lyons M, et al. Impact of Tourniquet Use in Major Lower Limb Amputation: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2024. PMID: 39293555. doi:10.1016/j.ejvs.2024.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。